Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1321-2026Class I

Reprocessed Livewire Steerable Diagnostic Electrophysiology Catheters: Livewire Steerable Electrophysiology...

MEDLINE INDUSTRIES, LP - Northfield / initiated 2025-12-22 / Open, Classified

Medline Industries, LP began a recall of Reprocessed Livewire Steerable Diagnostic Electrophysiology Catheters: Livewire Steerable Electrophysiology Catheter,10 Elec. 2-5-2mm 401582RH 401940RH... on . FDA classified it as Class I and gives the reason as "These lots of reprocessed catheters may contain small particles of residual material. If affected devices are used, there is a risk of inflammatory response, systemic infection, or granulomatous reaction or thrombus...". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-1321-2026
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
MEDLINE INDUSTRIES, LP - Northfield
Product
Reprocessed Livewire Steerable Diagnostic Electrophysiology Catheters: Livewire Steerable Electrophysiology Catheter,10 Elec. 2-5-2mm 401582RH 401940RH; Livewire Steerable Electrophysiology Catheter,20 Elec. 2-10-2mm 401904RH; Livewire Steerable Electrophysiology Catheter,20 Elec. 2-5-2mm 401914RH; Livewire Steerable Electrophysiology Catheter,20 Elec. 2-8-2-60-2-8-2mm 401932RH; Livewire Steerable Electrophysiology Catheter,8 Elec. 2-2-2mm 401652RH;
Product code
NLH Catheter, Recording, Electrode, Reprocessed
Reason for recall
These lots of reprocessed catheters may contain small particles of residual material. If affected devices are used, there is a risk of inflammatory response, systemic infection, or granulomatous reaction or thrombus reaction which may lead to cerebral or pulmonary embolism, or deep vein thrombosis. Expansion of recall Z-2610/2614-2025
FDA root cause
Under Investigation by firm
Action
On December 22, 2025, the firm issued Urgent Medical Device Recall letters as a follow-up to an earlier action in 2025 for the same issue, but newly identified item numbers and lots of previously identified item numbers. Notably, the products associated with the new/updated action are to be destroyed by the customer on-site for credit, and not returned to the manufacturer. ***Updated 5/18/26*** The firm issued an expanded notification on 5/15/26 which expanded the action to include on additional lot of product. These devices were not expired at the time of the original notification but have since expired.
Quantity in commerce
41
Distribution
Distribution US nationwide.
Product codes and lots
401582RH UDI-DI (case) 20888277407517¿ (ea) 10888277407510 Lots EP250618 EP250630; 401940RH UDI-DI 10888277407480 Lot EP250618; 401904RH UDI-DI (case) 20888277407609¿ (ea) 10888277407602 Lots EP250618 EP250630; 401914RH UDI-DI (case) 20888277407524¿ (ea) 10888277407527 Lot EP250618; 401932RH UDI-DI (case) 20888277407678¿ (ea) 10888277407671 Lots EP250618 EP250630; 401652RH UDI-DI 10888277407572 Lots EP250618 EP250630

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1321-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1319-2026Class IOngoingVoluntary: Firm initiated
Z-1320-2026Class IOngoingVoluntary: Firm initiated
Z-1321-2026Class IOngoingVoluntary: Firm initiated
Z-1322-2026Class IOngoingVoluntary: Firm initiated
Z-1323-2026Class IOngoingVoluntary: Firm initiated
Z-1324-2026Class IOngoingVoluntary: Firm initiated
Z-1325-2026Class IOngoingVoluntary: Firm initiated